Komorbiditäten

Alberti KGMM, Eckel RH, Grundy SM et al. (2009) Hamonizing the metabolic syndrome. A joint meeting interim statement of the international diabetes federation task force on epidemiology and prevention. Circulation 120:1640–1645

Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113–121PubMed

Adams TD, Gress RE, Smith SC et al. (2007) Long-term mortality after gastric bypass surgery. NEJM 57:753–761

Adult Treatment Panel III guidelines (2004) Circulation 110:227–239

Alpert MA, Terry BE, Mulekar M et al. (1997) Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss Am J Cardiol 80:736–740

Alpert MA, Lambert CR, Terry BE et al. (1995) Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive mobidly obese patients. Int J Obes 19:550–557

American College of Obstetricians and Gynecologists (2005) ACOG Committee Opinion 315. Obesity in pregnancy. ObstetGynecol 106:671–675

Amin AK, Clayton RA, Patton JT et al. (2006) Total knee replacement in morbidly obese patients. Results of a prospective, matched study. J Bone Join Surg 88:1321–1326

Andersen RE, Crespo CJ, Barlett SC et al. (2003) Relationship between body weight gain and significant knee, hip, and back pain in older Americans. Obesity Res 11:1159–1162

Ärnlöv J, Ingelsson E, Sundström J et al. (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation121:230–236PubMed

Aro P, Ronkainen J, Talley NJ et al. (2005) Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut 54:1377–1383PubMed

Aune D, Ursin G, Veierod MB (2009) Meat consumption and the risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies. Diabetologia 52:2277–2287PubMed

Ballard-Barbash R, Berrigan D et al. (2010) Obesity and cancer epidemiology. In: Berger NA (eds) Cancer and energy balance, epidemiology and overview. Springer Science+Business Media, New York. 1: 1–44

Banim PJR, Luben RN, Bulluck H et al. (2011) The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk) Eur J Gastroent Haematol 23:733–740

Baumgarten KM, Carlson WO, Watson ES (2011) The effect of obesity on orthopaedic conditions. S D Med Spec. No.:41–44

Bellver J, Melo MA, Bosch E, Serra V, Remohi J, Meseguer M (2007) Obesity and poor reproductive outcome: the potential role of the endometrium. FertilSteril 88:446–451

Bellver J, Cruz F, Martinez MC, Ferro J, Ramirez JF, Pellicer A, Garrido N (2011) Female overweight is not associated with a higher embryo euploidy rate in first trimester miscarriages karyotyped by hysteroembryoscopy. FertilSteril 96:931–933

Benraouane F, Litwin SE (2011) Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol 26:555–561PubMed

Beral V, Bull D et al. (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365:1543–1551PubMed

Berger NA (2010) Cancer and energy balance, epidemiology and overview. Springer Science+Business Media, New York

Bergmann A, Li J, Wang I et al. (2007) A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res 39:677–682PubMed

Blanco AT, Smilen SW, Davis, Loopez S, Lapinski R, Lockwood CJ (1998) Pregnancy outcome and weight gain recommendations for the morbidly obese woman. ObstetGynecol 91:97–102

Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32:14–23

Bodnar LM, Ness RB, Harger GF, Roberts JM (2005) Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 162:1198–1206PubMed

Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H et al. (2004) Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 17:904–910PubMed

Bray GA (2006) Obesity: the disease. J Med Chem 49:4001–4007PubMed

Brook RD, Bard RL, Rubenfire M (2001) Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 88:1264–1269PubMed

Brown SA, Upchurch S, Anding R, Winter M, Ramirez G (1996) Promoting weight loss in type II diabetes. Diabetes Care 16:613–624

Buchwald H, Estok R, Fahrbach K et al. (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256PubMed

Budweiser S, Riedl SG, Jörres RA et al. (2007) Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med 261:375–383PubMed

Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634–642PubMed

Butler AE, Janson J, Bonner-Weir S et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMed

Byers TR, Sedjo L (2011) Does intentional weight loss reduce cancer risk? Diabetes Obes Metab 13:1063–1072PubMed

Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591PubMed

Canoy D, Boekholdt SM, Wareham N et al. (2007) Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk Cohort. A population based prospective study. Circulation 116:2933–2943PubMed

Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J (2003) Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 133:1674–1683

Challier JC, Basu S, Bintein, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S (2008) Obesity in prernancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29:274–281PubMed

Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969PubMed

Chang SC, Lacey JV, Jr et al. (2007) Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 16:723–730PubMed

Chauhan SP, Magann EF, Carroll CS et al. (2001) Mode of delivery for the morbidly obese with prior cesarean delivery: vaginal versus repeat cesarean section. Am J ObstetGynecol 185:349–354

Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 1:CD007340PubMed

Chen A, Feresu SA, Fernandez C, Rogan WJ (2009) Maternal obesity and the risk of infant death in the United States. Epidemiology 20:74–81PubMed

Christensen R, Bartels EM, Astrup A et al. (2007) Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 66:433–439PubMed

Christou NV, Sampalis JS, Liberman M et al. (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416–424PubMed

Cnattingius S, Bergström R, Lipworth L, Kramer MS (1998) Prepregnancy weight and the risk of adverse outcomes. N Engl J Med 338:147–152PubMed

Coggon D, Reading I, Croft P et al. (2001) Knee osteoarthritis and obesity. Int J Obes 25:622–627

Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science. 332:1519–1523PubMed

Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes in women. Ann Intern Med 122:481–486PubMed

Corley DA, Kubo A, Levin TR et al. (2007) Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology 133:34–41PubMed

Coughlin SR, Mawdsley L, Mugarza JA et al. (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741PubMed

Cremer P et al. (1994) Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS) Eur J Clin Invest 24:444–453PubMed

Davis AM, Wood AM, Keenan ACM et al. (2011) Does body mass index affect clinical outcome post-operatively and at five years after primary unilateral total hip replacement performed for osteoarthritis? J Bone Joint Surg Br 93:1178–1182PubMed

De Groot NL, Burgerhart JS, van de Meeberg PC et al. (2009) Systematic review: effects of conservative and surgical treatment for obesity on gatro-oesophagel reflux disease. Aliment Pharmacol Ther 30:1091–1102PubMed

De Luca C, Olefsky JM (2006) Stressed out about obesity and insulin resistance. Nat Med 12:41–42PubMed

Denison FC, Roberts KA, Barr SM, Norman JE (2010) Obesity, pregnancy, inflammation and vascular function. Reproduction 140:373–385PubMed

Despres JP (1994) Dyslipidaemia and obesity. Baillieres Clin Endocrinol Metab 8:629–660PubMed

Desbeaux A, Hec F, Andrieux S et al. (2010) Risk of biliary complications in bariatric surgery. J. Visceral Surgery 147:e217–e220

Deutsche Gesellschaft für Ernährung (2006) Evidenzbasierte Leitlinie: Fettkonsum und Prävention ausgewählter ernährungsmitbedingter Erkrankungen, Version 2006. http://www.dge.de

De Voos AM, Prokop M, Roos CJ et al. (2008) Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors und coronary calcification in post-menopausal women. Eur Heart Journal 29:777–783

Ding J, Visser M, Kritchevsky SB, Nevitt M, Newman A, Sutton-Tyrrell K et al. (2004) The association of regional fat depots with hypertension in older persons of white and African American ethnicity. Am J Hypertens 17:971–976PubMed

Dodd JM, Grivell RM, Crowther CA, Robinson JS (2010) Antenatal interventions for overweight or obese pregnant women: a systematic review of randomized trials. BJOG 117:1316–1326PubMed

Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V (2002) Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int J Obes 26:48–57

Duffey KJ, Popkin BM (2011) Energy density, portion size, and eating occasions: contributions to increased energy intake in the United States, 1977–2006. PLoS Med 8:e1001050PubMed

Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC (2011) Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 124:1046–1058PubMed

Ehrenberg HM, Dierker L, Milluzzi C, Mercer BM (2002) Prevalence of maternal obesity in an Urban center. Am J ObstetGynecol 187:1189–1193

Ehrenberg HM, Iams JD, Goldenberg RL, Newman RB, Weiner SJ, Sibai BM, Caritis SN, Mlodovnik M, Dombrowski MP (2009) Maternal obesity, uterine activity and the risk of spontaneous preterm birth. Am J ObstetGynecol 113:48–52

Eknoyan G (2011) Obesity and chronic kidney disease. Nefrologia 31:397–403PubMed

Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45:356–362PubMed

Eslick GD (2011) Gastrointestinal symptoms and obesity: a meta-analysis. Obesity Reviews 12:1–11

Everhart JE (1993) Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 119:1029–1035PubMed

Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50:1072–1078PubMed

Felson DT, Anderson JJ, Naimark A et al. (1988) Obesity and knee osterarthritis. The Framingham Study. Ann Int Med 109:18–24PubMed

Felson DT, Edmond SL (2003) Orthopedic complications. In: Obesity. Mechanisms and clinical management, edt. by R.H. Eckel, Lippincodt, Philadelphia 399–414

Felson DT, Zhang Y, Antony YJM et al. (1992) Weight loss reduces the risk for symptomatic knee osteoarthritis in women. Ann Int Med 116:535–539PubMed

Fox CS, Gona P, Hoffmann U (2009) Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function. The Framingham Heart Study. Circulation 119:1586–1591

Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48PubMed

Frankel DS, Vasan RS, D’Agostino RB et al. (2009) Resistin, adiponectin, and risk of heart failure. JACC 53:754–762PubMed

Friedenreich CM (2011) Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 188:125–139PubMed

Friedenreich CM, Cust A et al. (2007) Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 18:399–413PubMed

Friedenreich CM, Neilson HK et al. (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46:2593–2604PubMed

Funell MM (2010) Standards of care for diabetes: what’s new? Nursing 2010;40:54–56. American Diabetes Association. Standards of medical care in diabetes 2010. Diabetes Care 33:11

Fyfe EM, Anderson NH, North RA, Chan EH, Taylor RS, Dekker GA, McCowan LM (2011) Risk of first stage and second-stage cesarean delivery by maternal body mass index among nulliparous women in labor at term. ObstetGynecol 117:1315–1322

Gallagher EJ, LeRoith D, Karnieli D (2010) Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mount Sinai J Med 77:511–523

Gastaldelli A, Kozakova M, Højlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B; RISC Investigators (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537–1544PubMed

Gill RS, Al-Adra DP, Shi X et al. (2011) The benefits of bariatric surgery in obese patients with hip and knee osteoarthritis: a systematic review. Obesity Rev 12:1083–1089

Giugliano G, Brevetti G, Laurenzano E et al. (2010) The prognostic impact of general and abdominal obesity in peripheral arterial disease. Int J Obes 34:280–286

Glazer NL, Hendrickson AF, Schellenbaum GD, Mueller BA (2004) Weight change and the risk of gestational diabetes in obese women. Epidemiology 15:733–737PubMed

Getahun D, Ananth CV, Peitier MR, Salihu HM, Scorca WE (2007a) Changes in prepregnancy body mass index between the first and second pregnancies and risk of large-for-gestational-age birth. Am J ObstetGynecol 197:376.e1–7

Getahun D, Kaminsky LM, Elsasser DA, Kirby RS, Ananth CV, Vintzileos AM (2007b) Changes in prepregnancy body mass index between pregnancies and risk of primary cesarean delivery. Am J ObstetGynecol 197:376.e1–7

Grassi G, Seravalle G, Dell’Oro R, Turri C, Bolla GB, Mancia G (2000) Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 36:538–542PubMed

Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF (2007) The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med 45:348–352PubMed

Grundy SM et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004;44:720-32

Grundy SM, Cleeman JI, Daniels SR et al. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lund, and Blood Institute Scientific Statement. Executive Summary. Circulation112:2735–2752

Guh DP, Zhang W et al. (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88PubMed

Habbu A, Lakkis NM, Dokainish H (2006) The obesity paradox: fact or fiction? Am J Cardiol 98:944–948PubMed

Hall JE (2003) The kidney, hypertension, and obesity. Hypertension 41:625–633PubMed

Hall JE, Da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S et al. (2010) Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 285:17271–17276PubMed

Hampel H, Abraham NS, El-Serag HE (2005) Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and it‘s complications. Ann Int Med 143:199–211PubMed

Han TS, Schouten JSAG, Lean MEJ et al. (1997) The prevalence of low back pain and associations with body fatness, fat distribution and height. Int J Obes 21:600–607

Hartmann B, Junger A, Klasen J (2005) Anästhesie und Schlaf-Apnoe-Syndrom. Anaesthesist 54:684–693PubMed

Harvie M, Howell A et al. (2005) Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev 14:656–661PubMed

Haufe S, Utz W, Engeli S, Kast P, Böhnke J, Pofahl M et al. (2012) Left ventricular mass and function with reduced-fat or reduced-carbohydrate hypocaloric diets in overweight and obese subjects. Hypertension 59:70–75PubMed

Hauner H (2005a) Epidemiologie und Kosten des Diabetes mellitus. Dtsch Med Wochenschr 130:S64–S65

Hauner H (2005b) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64:163–169

Hauner H, Buchholz G, Hamann A, Husemann B, Koletzko B, Liebermeister H, Wabitsch M, Westenhöfer J, Wirth A, Wolfram G (2011) Adipositas und Diabetes mellitus. Praxis-Leitlinie der Deutschen Diabetes-Gesellschaft. Diabetol Stoffw 6:S137–S142

Hauner H, Köster I, Schubert I (2007) Trends in der Prävalenz und ambulanten Versorgung von Menschen mit Diabetes mellitus im Zeitraum 1998 bis 2004: eine Analyse der Versichertenstichprobe AOK Hessen/KV Hessen. Dt Ärztebl 104:A2799–A2805

Hauner H, Much D, Vollhardt C, Brunner S, Schmid D, Sedlmeier EM, Helmberg E, Schuster T, Zimmermann A, Schneider KTM, Bader BL, Amann-Gassner U (2012) Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy on infant adipose tissue growth within the first year of life: an open-label randomized trial. Am J ClinNutr 95:383–394

Hebebrand J, Dabrock P, Lingenfelder M et al. (2004) Ist Adipositas eine Krankheit? Interdisziplinäre Perspektiven. Dtsch Ärztebl 101:C2001–C2007

Hibbard JU, Gilbert S, Landon MB, Hauth JC, Leveno KJ, Spong CY, Varner MW, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Mlodovnik M, Carpenter M, Peaceman AM, O`Sullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM, Gabbe SG (2006) Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. ObstetGynecol 108:125–133

Hofsø D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollerslev J, Godang K, Sandbu R, Røislien J, Hjelmesaeth J (2010) Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 163:735–45PubMed

Hooper MM, Stellato TA, Hallowell PT et al. (2007) Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes 31:114–120

Horwich TB, Hamilton MA, Fanarow GC (2006) B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll 47:85–90

Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900–917PubMed

Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43:1271–1278PubMed

Hsu CY, McCulloch CE, Irivarren C et al. (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21–28PubMed

Hu G, Jousilahti P, Antikainen R et al. (2010) Joint effects of physical activity, body mass index, waist circumference, and waist-to-hip ratio on the risk of heart failure. Circulation 121:237–244PubMed

Huang Z, Willett WC, Manson JE et al. (1998) Body weight, weight change, and risk for hypertension in women. Ann Intern Med 128:81–88PubMed

Hube F, Hauner H (1999) TNF-α in human adipose tissue: prevention of weight gain at the expense of insulin resistance. Horm Metab Res 31:626–631PubMed

Hubert HB, Feinlieb M, McNamara PM et al. (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 67:968–977PubMed

International Diabetes Federation (2005) The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/Metab_Syndrome_def.pdf

Ishikawa Y et al. (2001) The distribution and production of cholesteryl ester transfer protein in the human aortic wall. Atherosclerosis 156:29–37PubMed

Jacobson BC, Somers SC, Fuchs CS (2006) Body-mass index and symptoms of gastroesophageal reglux in women. NEJM 354:2340–2348PubMed

Janssen I, Mark AE (2006) Separate and combined influence of body mass index and waist circumference on arthritis and knee osteoarthritis. Int J Obes 30:1223–1228

Jinks C, Jordan K, Croft P (2006) Disabling knee pain – another consequence of obesity: results from a prospective cohort study. BMC Public Health 6:258–265PubMed

Jitrapakdee S, Wutthisathaporuchai A, Wallace JC, MacDonald MJ (2010) Regulation of insulin secretion: role of mitochondrial signalling. Diabetologia 53:1019–1032PubMed

Jordan J, Schlaich M, Redon J, Narkiewicz K, Luft FC, Grassi G, Dixon J, Lambert G, Engeli S (2011) European Society of Hypertension Working Group on Obesity; Australian and New Zealand Obesity Society. Obesity drugs and cardiovascular outcomes. J Hypertens 29:189–193PubMed

Kaaks R, Lukanova A et al. (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531–1543PubMed

Kaaks R, Rinaldi S et al. (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071–1082PubMed

Kahn R, Buse J, Ferrannini E et al. (2005) The metabolic syndrome: time for a critical appraisal. Diabetes Care 28:2289–2304PubMed

Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846PubMed

Kenchaiah S, Evans JC, Levy D et al. (2002) Obesity and the risk of heart failure. N Engl J Med 347:305–313PubMed

Kenchaiah S, Pocock SJ, Wang D et al. (2007) Body mass index and prognosis in patients with chronic heart failure. Insights from the Candesartan in Heart Failure: Assessment of reduction in mortality and morbidity (CHARM) program. Circulation 116:627–636PubMed

Kerner W, Brückel J (2010) Definition, Klassifikation und Diagnostik des Diabetes mellitus. Praxisleitlinien der Deutschen Diabetes-Gesellschaft. Diabetol Stoffw 5:S109–S112

Key TJ, Appleby PN et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218–1226PubMed

Key TJ, Pike MC (1988) The dose-effect relationship between ’unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57:205–212PubMed

Kirk JK, Graves DE, Craven TE et al. (2008) Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. J Am Diet Assoc 108:91–100PubMed

Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74:761–811PubMed

Klöting N, Fasshauer M, Dietrich A et al. (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299:E506–E515PubMed

Knowler WC, Barrett-Connor E, Fowler SE et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMed

Köster I, Huppertz E, Hauner H, Schubert I (2011) Direct costs of diabetes mellitus in Germany 2000–2007: long-term analysis of the sample AOK/KV Hesse. Exp Clin Endocrinol & Diabetes 119:377–385

Kominiarek MA, Zhang J, Vanveldhuisen P, Troendle J, Beaver J, Hibbard JU (2011) Contemporary labor patterns: the impact of maternal body mass index. Am J ObstetGynecol 244:1–8

Koskinen J, Magnussen CG, Taittonen L et al. (2010) Arterial structure and function after recovery from the metabolic syndrome. Circulation 121:392–400PubMed

Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J, Petersen KF, Samuel VT, Shulman GI (2011) Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA. 108:16381–16385PubMed

LaCoursiere DY, Bloebaum L, Duncan JD, Varner MW (2005) Population-based trends and correlates of maternal overweight and obesity, Utah 1991–2001. Am J ObstetGynecol 192:832–839

Lafontan M (2005) Fat cells; afferent and efferent messages define new approaches to treat obesity. Ann Rev Pharmacol Toxicol 2005;45:119-46

Lakka HM, Laaksonen, Lakka TA et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716PubMed

Li Z, Hong K, Saltsman P et al. (2005) Long-term efficacy of soy-based meal replacement vs. an individualized diet plan in obese type II diabetic patients: relative effects on weight loss, metabolic parameters and C-reactive protein. Eur J Clin Nutr 59:411–418PubMed

Littleton SW (2012) Impact of obesity on respiratory function. Respirology 17:43–49PubMed

Look AHEAD Research Study Group (2007) Reduction in weight and cardiovascular risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 30:1374–1383

Look AHEAD Research Group (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD Trial. Arch Intern Med 170:1566–1575

Lteif AA, Han K, Mather KJ (2005) Obesity, insulin resistance, and the metabolic syndrome. Determinants of endothelial dysfunction in whites and blacks. Circulation 112:32–38

Lu GC, Rouse DJ, DuBard M Cliver S, Kimberlin D, Hauth JC (2001) The effect of increasing prevalence of maternal obesity on perinatal morbidity. Am J ObstetGynecol 185:845–849

Lu B, Zhou J, Waring ME et al. (2010) Abdominal obesity and peripheral vascular disease in men and women: a comparison of waist-to-thigh ratio and waist circumference as measures of abdominal obesity. Atherosclerosis 208:253–257PubMed

Lukanova A, Lundin E et al. (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108:425–432PubMed

Mack I, BelAiba RS, Djordjevic T, Görlach A, Hauner H, Bader BL (2009) Human preadipocytes under normoxia, hypoxia and TNF-α exposure are activators of human microvascular endothelial cells in co-culture – a situation different for normoxic adipocytes. Am J Physiol Endocrin Metab 134:E735–E748

Maggard MA, Yermilov I, Liz Z, Maglione M, Newberry S, Suttorp M, Hilton L, Santry HP, Morton JM, Livingston EH, Shekelle PG (2008) Pregnancy and fertility following bariatric surgery; a systematic review. JAMA 300:2286–2296PubMed

Malik VS, Popkin BM, Bray GA et al. (2010) Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 33:2477–2483PubMed

Mancia G et al. (2007) Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25:1105–1187

Manson JE et al. (1995) Body weight and mortality among women. N Engl J Med 333:677–685PubMed

Masurek T, Zhang L, Zalewski A et al. (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108:2460–2466

Marin JM, Carrizo SJ, Vicente E et al. (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure : an observational study. Lancet 365:1046–1053PubMed

Marks R, Allegrante JP (2002) Body mass indices in patients with disabling hip ostearthritis. Arthritis Res 4:112–116PubMed

Martin BC, Warram JH, Krolewski AS et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929PubMed

Matthaei S, Bierwirth R, Fritsche A et al. (2009) Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2. Diabetol Stoffw 4:32–64

McCarthy IM (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339–2350PubMed

McCloskey CA, Ramani GV, Mathier MA et al. (2007) Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surgery Obes Rel Diseases 3:503–507

McGill HC, McMahan CA, Hederick EE et al. (2002) Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105:2712–2718PubMed

Messier SP (2008) Obesity and osteoarthritis: disease genesis and nonpharmalogical weight management. Rheum Dis Clin North Am 34:713–729PubMed

Metwally M, Ong KJ, Ledger WL, Li TC (2008) Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. FertilSteril 90:714–726

Miller GD, Niklar BJ, Davis C et al. (2006) Intensive weight loss program improves physical function in older obese adults with knee osteoarthritis. Obesity 14:1219–1230PubMed

Moebus S, Hanisch J, Bramlage P et al. (2008) Regional unterschiedliche Prävalenz des metabolischen Syndroms. Dtsch Ärztebl 105:207–213

Musso G, Cassader M, Rosina F, Gambino R (2012) Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials Diabetologia 55:885–904

Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282:1523–1529PubMed

Myles TD, Gooch J, Santolaya J (2002) Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. ObstetGynecol 100:959–964

Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK (1998) Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98:772–776PubMed

Navab M et al. (2011) HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8:222–232PubMed

Neter JE, Sam BE, Kok FJ, Grobbee DE, Geleijnse JM (2003) Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 42:878–884PubMed

Nock NL, Berger NA (2010) Obesity and cancer: overview of mechanisms. In: Berger NA (ed.) Cancer and energy balance, epidemiology and overview. Springer Science+Business Media, New York. 1:129–179

O`Brien TE, Ray JG, Chan WS (2003) Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14:368–374

Ong KK (2006) Size at birth, postnatal growth and risk of obesity. HormRes 65:65–69

Oreopoulos A, Padwal R, Kalantar-Zadeh K et al. (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156:13–22PubMed

Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roque I, Figuls M, Richter B, Mauricio G (2008) Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev CD003054

Owens LA, O`Sullivan EP, Kirwan B, Avalos G, Gaffney G, Dunne F; ATLANTIC DIP Collaborators (2010) ATLANTIC DIP: the impact of obesity on pregnancy outcome in glucose-tolerant women. Diebetes Care 22:577

Parhofer KG (2011) Pathophysiology of diabetic dyslipidemia: implications for atherogenesis and treatment. Clin Lipidol 6:401–411

Parhofer KG, Laubach E, Barrett PH (2003) Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients. J Lipid Res 44:1192–1198PubMed

Paz-Filho G, Lim EL et al. (2011) Associations between adipokines and obesity-related cancer. Front Biosci 16:1634–1650

Petersen KF, Dufour S, Befroy D et al. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671PubMed

Phielix E, Szendroedi J, Roden M (2011) The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact. Trends Pharmacol Sci 32:607–616PubMed

Phipps PR, Starritt E, Caterson I et al. (2002) Association of serum leptin with hypoventila-tion in human obesity. Thorax 57:75–76PubMed

Piper AJ, Grunstein RR (2011) Obesity hypoventilation syndrome. Am J Respir Crit Care Med 183:292–298PubMed

Pisani P (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114:63–70PubMed

Planas A, Clara A, Pou JM et al. (2001) Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men. Int J Obes 25:1068–1070

Polonsky KS, Sturis SJ, Bell GI (1996) Non-insulin-dependent diabetes mellitus – a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777–783PubMed

Poobalan AS, Aucott LS, Gurung T, Smith WC, Bhattacharya S (2001) Obesity as an independent risk factor for cesarean in a low-risk population. ObstetGynecol 97:39

Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V; LIDO Study Group; CYTOL study group (2006) Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 6:34PubMed

Rabkin SW (2007) Epicardial fat: properties, function and relationships to obesity. Obesity reviews 8:253–261PubMed

Randle PJ, Hales CN, Garland PB et al. (1963) The glucose-fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus. Lancet 785–789

Rathmann W, Haastert B, Icks A et al. (2003) High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182–189PubMed

Rathmann W, Haastert B, Icks A et al. (2006) Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with c-reactive protein. Diabetes Care 29:1095

Reaven GM (1988) Role of insulin resitance in human disease. Diabetes 37:1495–1607

Reaven GM (2003) The insulin resistance syndrome. Current Atherosclerosis Reports 5:364–371PubMed

Reeves GK, Beral V et al. (2006) Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 7:910–918PubMed

Reddy UM, Branum AM, Klebanoff MA (2005) Relationship of maternal body mass index and height to twinning. ObstetGynecol 105:593–597

Redolfi S, Yumino D, Ruttanaumpawan P et al. (2009) Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 179:241–246PubMed

Reijman M, Pols HAP, Bergink AP et al. (2007) Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 66:158–162PubMed

Renehan AG, Soerjomataram I et al. (2010) Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 126:692–702PubMed

Renehan AG, Tyson M et al. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMed

Renehan AG, Zwahlen M et al. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353PubMed

Rexrode KM, Carey VJ, Hennekens CH (1998) Abdominal adiposity and coronary heart disease in women. JAMA 280:1843–1848PubMed

Riegel B, Moser DK, Anker SD (2009) State of the science. Promoting self-care in persons with heart failure. A scientific statement from the American Heart Association. Circulation 120:1141–1163

Ritte RE, Lukanova A et al. (2012) Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res 14:R76PubMed

RKI, GEKID (2010) Krebs in Deutschland 2005/2006. Häufigkeiten und Trends. 7. Ausgabe. Robert-Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg) Berlin

Roberts DL, Dive C et al. (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316PubMed

Robinson HE, O`Conell CM, Joseph KS, McLead NL (2005) Maternal outcomes in pregnancies complicated by obesity. ObstetGynecol 106:1357–1364

Roden M (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2:335–348PubMed

Rogers I, EURO-BLCS Study group (2003) The influence of birth weight and intrauterine environment on adiposity and fat distribution in later life. Int J ObesRelatMetabDisord 27:755–777

Romero-Corral A, Montori VM, Somers VK (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666–678PubMed

Ronnberg AK, Nilsson K (2010) Interventions during pregnancy to reduce excessive gestational weight gain: a systematic review assessing current clinical evidence using the grading of recommendations, assessment, development and evaluation (GRADE) system. BJOG 117:1327–1334PubMed

Rosito GA, Massaro JM, Hoffmann U et al. (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample. The Framingham Heart Study. Circulation 117:605–613

Ross WR, McGill JB (2006) Epidemiology of obesity and chronic kidney disease. Advances Chronic Kidney Diseease 13:325–335

Runkel N, Colombo-Benkmann M, Hüttl TP, Tigges H, Mann O, Sauerland S (2011) Chirurgie der Adipositas. Dtsch Ärztebl Int 108:341–346PubMed

Sacks FM et al. (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360:859–873PubMed

Saely CH, Koch I, Schmid F et al. (2006) Adult treatment panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29:901–907PubMed

Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H (2006) Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Am J Clin Nutr 84:427–433PubMed

Schulte H, Cullen P, Assmann G (1999) Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM) Atherosclerosis 144:199–209PubMed

Schulz R, Eisele HJ, Weissmann N et al. (2006) Obstruktive Schlaf-Apnoe : ein wichtiger kardiovaskulärer Risikofaktor. Deutsches Ärzteblatt 103:775–781

Schulze MB, Schulz M, Heidemann C, Schiekewitz A, Hoffmann K, Boeing H (2007) Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 167:956–965PubMed

Schulze MB, Hoffmann K, Boeing H et al. (2007) An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30:510–515PubMed

Schulze M, Hauner H (2011) Kohlenhydratzufuhr und Prävention des Diabetes mellitus Typ 2. Kapitel 4. In: Evidenzbasierte Leitlinie: Kohlenhydrate und Prävention ausgewählter ernährungsmitbedingter Krankheiten Version 2011 der Deutschen Gesellschaft für Ernährung, Bonn, S. 58–74

Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S (2001) Maternal obesity and pregnancy outcome: a study of 287.213 pregnancies in London. Int J Obes Relat Metab Disord 25:1175–1182PubMed

Shahar E, Whitney CW, Redline S et al. (2001) Sleep-disordered breathing and cardiovascular disease. Cross-sectional results from the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25PubMed

Shiri R, Karppinen J, Leino-Arjas P et al. (2010) The association between obesity and low back pain: a meta-analysis. Am J Epidemiol 171:135–154PubMed

Shiri R, Solovieva S, Husgafvel-Purslainen K et al. (2008) The association between obesity and the prevalence of low back pain in young adults. Am J Epidem 167:1110–1119

Shoelsen SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793–1801

Shulman GI (200) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176

Siegel AB, Zhu AX (2009) Metabolic syndrome and hepatocellular carcinoma – two growing epidemics with a potential link. Cancer 115:5651–5661PubMed

Sierra-Johnson J, Romera-Corral A, Somers VK (2008) Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehab 15:336–340

Sise A, Friedenberg FK (2008) A comprehensive review of gastroesophageal reflux disease and obesity. Obesity Reviews 9:194–203PubMed

Sjöström L, Gummesson A et al. (2009) Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 10:653–662PubMed

Sjöström CD, Lystig T, Lindroos AK (2011) Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study. Int J Obes 35:1413–1420

Sjöström L, Lindroos AK, Peltonen M et al. (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693PubMed

Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H et al. (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65PubMed

Skurk T, Alberti-Huber C, Herder C, Hauner H (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92:1023–1033PubMed

Smith BW, Adams LA (2011) Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 7:456–465PubMed

Soens MA, Birnbach DJ, Ranasinghe JS, van Zundert A (2008) Obstetric anesthesia for the obese and morbidly obese patient: an ounce of prevention is worth more than a pound of treatment. Acta Anaesthesiol Scand 52:6–19PubMed

Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, Nalls MA, Clark JM, Mitchell BD, Shuldiner AR, Butler JL, Tomas M, Hoffmann U, Hwang SJ, Massaro JM, O’Donnell CJ, Sahani DV, Salomaa V, Schadt EE, Schwartz SM, Siscovick DS; NASH CRN; GIANT Consortium; MAGIC Investigators, Voight BF, Carr JJ, Feitosa MF, Harris TB, Fox CS, Smith AV, Kao WH, Hirschhorn JN, Borecki IB; GOLD Consortium (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7:e1001324PubMed

Sprecher DL, Pearce GL (2000) How deadly is the deadly quartet? J Am Coll Caridiol 36:1159–1165

Starley BQ, Calcagno CJ, Harrison SA (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51:1820–1832PubMed

Stothardt KJ, Tennant PW, Bell R, Rankin J (2009) Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 301:636–650

Stelfox HT, Ahmed SB, Ribeiro RA, Gettings EM, Pomerantsev E, Schmidt U (2006) Hemodynamic monitoring in obese patients: the impact of body mass index on cardiac output and stroke volume. Crit Care Med 34:1243–1246PubMed

Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189:W320–W323PubMed

Straznicky N et al. (2010) European Society of Hypertension Working Group on Obesity antihypertensive effects of weight loss: myth or reality? J Hypertens 28:637–643

Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R et al. (2006) Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens 24:1633–1639

Strazullo P, D’Elia L, Cairella G et al. (2010) Excess body weight and incidence of stroke. Meta-analysis of prospective studies with 2 million participants. Stroke 41:e418–e426

Stumvoll M, Goldstein BJ, van Haeften TW (2008) Type 2 diabetes, pathogenesis and treatment. Lancet 371:2153–2156PubMed

Sullivan CE, Issa FG, Berthon-Jones M et al. (1981) Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 317:862–865

Svedberg J, Strömblad G, Wirth A et al. (1991) Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest 88:2054–2058PubMed

Suzuki R, Orsini N et al. (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status – a meta-analysis. Int J Cancer 124:698–712PubMed

Szendroedi J, Phielix E, Roden M (2011) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 8:92–103PubMed

Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.N Engl J Med 363:1341–1350

Teucher B, Rohrmann S et al. (2010) Obesity: focus on all-cause mortality and cancer. Maturitas 65:112–116PubMed

Tuomilehto J, Lindstrom J, Eriksson JG et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMed

UK Prospective Diabetes Study Group (UKPDS) (1995) UK prospective diabetes study 16. Overview of 6 year therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258

United Kingdom Prospective Diabetes Study Group (UKPDS) (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352:854–865

United Kingdom Prospective Diabetes Study Group (UKPDS) 24 (1998) A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type-2-diabetes that could not be controlled with diet therapy. Ann Intern Med 128:165–175

Unger RH, Scherer PE (2010) Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 21:345–352PubMed

UshaKiran TS, Hemmadi S, Bethel J, Evans J (2005) Outcome of pregnancy in a woman with an increased body mass index. BJOG 112:768–772

Utz W, Engeli S, Haufe S et al. (2011) Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women. Heart 19:1585–1589

Vemmos K, Ntaios G, Spengos K (2011) Association between obesity and mortality after acute first-ever stroke. The obesity-stroke paradox. Stroke 42:30–36PubMed

Vettor ML, Cardillo S, Rickels MR, Iqbal W (2009) Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 150:94–103

Villamor E, Cnattingius S (2006) Interpregnancy weight change and risk of adverse pregnancy outcomes: a population – based study. Lancet 368:1164–1170PubMed

Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL (2012) Effects of glucagon-like peptide-1 agonists on weight loss : systemic review and meta-analysis of randomised controlled trials. BMJ 344:d7771PubMed

Voigt M, Straube S, Olbertz D, Häuser B, Schneider KTM (2007) Beziehungen zwischen Körpergewicht, Körperhöhe, Body-Mass-Index und der Gewichtszunahme von Frauen in der Schwangerschaft. Z GeburtshNeonatol 211:147–152

Voigt M, Straube S, Zygmunt M, Krafcyk B, Schneider KTM (2008) Obesity and pregnancy – a risk profile. Z GeburtshNeonatol 212:201–205

Wang Y, Cheng X, Sonmg Y et al. (2008) Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73:19–33PubMed

WCRF (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC, World Cancer Research Fund/American Institute of Cancer Research

Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Häring HU, Boeing H, Fritsche A (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555–2562PubMed

Weyer C, Foley JE, Bogardus C et al. (2000) Enlarged subcutaneous abdominal adipocyte size, but not obesity itself predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498–1506PubMed

Whitmer RA, Gunderson EP, Barrett-Connor E et al. (2005) Obesity in middle age and future risk of dementia; a 27 year longitudinal population based study. BMJ 330:1360–1365PubMed

Wildman RP et al. (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004) Arch Intern Med 168:1617–1624PubMed

Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867–1872PubMed

Winter Y, Rohrmann S, Linseisen J et al. (2010) Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 39:3145–3151

Wirth A (2007) Adipositas – eine Krankheit? Cardiovasc 7:28–34

Wirth A et al. (1986) Combination therapy of obesity with a reducing diet and physical training. Cardiovascular and metabolic effects. Dtsch Med Wochenschr 111:972–977

Wormser D, Kaptoge S, Di Angelantonio E et al. (2011) Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 377:1085–1095PubMed

Xu WL, Atti AR, Gatz MG et al. (2011) Midlife overweight and obesity increase late-life dementia. A population-based twin study. Neurology 76:1568–1574PubMed

Ye J (2009) Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes Relat Metab Disord 33:54–66

Yki-Järvinen H, Ryysi L, Kauppila M et al. (1997) Effect of obesity on the response to insulin therapy in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:4037–4043PubMed

Young T, Palta M, Dempsey J et al. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235PubMed

Young T, Finn L, Peppard PE et al. (2008) Sleep disordered breathing and mortality : eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31:1071–1078PubMed

Yusuf S, Hawken S Ounpuu S et al. (2005) Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 366:1640–1649PubMed

Zhang F et al. (2011) Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG) Obes Surg 21:305–309

Zhang J, Bricker L, Wray S, Qenby S (2007) Poor uterine contractility in obese women. BJOG 114:343–348PubMed

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

6. Komorbiditäten

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin